ICAM1 and prostate carcinoma: The down-regulation of ICAM1 mediated by ectopic expression of miRNA-296-3p in prostate cancer could facilitate metastasis by reducing susceptibility of circulating tumor cells to cytotoxicity by nature killer (NK) cells though inhibition of NK cell activation and expansion (70).